Search Results - "Spurden, D"

HaemoPREF: Further evaluation of patient perception and preference for treatment in a real world setting by Bonanad, S., Schulz, M., Gordo, A., Spurden, D., Cicchetti, M., Cappelleri, J. C., Tolley, C., Staunton, H., Brohan, E.

“…Introduction Adherence to haemophilia A (HA) treatment may be influenced by patients’ beliefs about their condition and treatment. Furthermore, difficulties…”
Get full text

Mattress type for improving outcomes for chronic low-back pain: a systematic review by Hailey, L, Roberts, N, Spurden, D, Wray, J, Burls, A

Get full text

PCR164 Adherence to Botulinumtoxin Treatment: A 2-Year Retrospective Claims Database Analysis by Simpson, D.M., Bouchard, J., Page, S., Spurden, D., Goldfarb, S., Patel, A.T.

Get full text

PCN247 CHARACTERISTICS OF USERS AND PRESCRIBERS OF CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) AMONG MEDICARE AND NON-MEDICARE PATIENTS WITH HUMAN RECEPTOR POSITIVE / HUMAN EPIDERMAL GROWTH FACTOR 2 NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC) BREAST CANCER IN THE UNITED STATES (US), 2015-2018 by Petrilla, A., Mohammadi, I., Shen, X., Spurden, D., Mitra, D.

Get full text

Clinical neurochemistry: developments in dementia research based on brain bank material by Perry, E, Court, J, Goodchild, R, Griffiths, M, Jaros, E, Johnson, M, Lloyd, S, Piggott, M, Spurden, D, Ballard, C, McKeith, I, Perry, R

“…Brain tissue obtained at autopsy continues to provide unique opportunities in current dementia research. Not only is tissue analysis still essential for…”
Get full text

82P A multinational study of real-world treatment patterns among patients with early stage HR+/HER2- breast cancer (BC) by Criscitiello, C., Spurden, D., Rider, A., Williams, R., Corsaro, M., Pike, J., Law, E.H.

Get full text

87P Patient-reported and cancer-specific health-related quality of life among patients with early stage HR+/HER2- breast cancer (BC) by Criscitiello, C., Spurden, D., Rider, A., Williams, R., Corsaro, M., Pike, J., Law, E.H.

Get full text

88P Latent class analysis (LCA) to identify and describe clinically relevant subgroups in a multinational study of patients with HR+/HER2- early breast cancer (eBC) by Rider, A., Spurden, D., Williams, R., Corsaro, M., Pike, J., Law, E.H., Criscitiello, C.

Get full text

Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [ 3H]nicotine and [ 125I] α-bungarotoxin binding by Spurden, D.P, Court, J.A, Lloyd, S, Oakley, A, Perry, R, Pearson, C, Pullen, R.G.L, Perry, E.K

“…The thalamus plays a major role in relaying and transforming information that is relayed to the cortex and in turn modulates cortical outputs. The reticular…”
Get full text

CN1 HEALTH RELATED QUALITY OF LIFE AMONG PATIENTS WITH EARLY BREAST CANCER: A MULTINATIONAL STUDY by Law, E., Spurden, D., Piercy, J., Williams, R., Corsaro, M., Pike, J., Criscitiello, C.

Get full text

PCN28 CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) IN HORMONE RECEPTOR-POSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC): A SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE (RWE) STUDIES by Harbeck, N., Bartlett, M., Spurden, D., Hooper, B., Zhan, L., Rosta, E., Cameron, C., Mitra, D., Zhou, A.

Get full text

PRM7 - THE USE OF NATURAL LANGUAGE PROCESSING TO ASSESS PATIENTS WITH BLEEDS IN THEIR NOTES IN THE OPTUM EHR DATABASE by Rubinstein, E, Spurden, D, Chhabra, A, Tortella, BJ, Fogarty, PF, Senerchia, C, Alvir, J

Get full text

PSY34 - Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan by Karumori, T, Chhabra, A, Alvir, J, Fogarty, PF, Spurden, D, Tortella, BJ, Rubinstein, E, Pleil, A

Get full text

Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products by Chhabra, A, Spurden, D, Tortella, BJ, Fogarty, PF, Pleil, A, Rubinstein, E, Alvir, J

Get full text

Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan by Karumori, T, Chhabra, A, Alvir, J, Fogarty, PF, Spurden, D, Tortella, BJ, Rubinstein, E, Pleil, A

Get full text

PSY35 - Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products by Chhabra, A, Spurden, D, Tortella, BJ, Fogarty, PF, Pleil, A, Rubinstein, E, Alvir, J

Get full text

PSY110 - Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products by Spurden, D, Chhabra, A, Tortella, BJ, Fogarty, PF, Rubinstein, E, Pleil, A, Alvir, J

Get full text

Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products by Spurden, D, Chhabra, A, Tortella, BJ, Fogarty, PF, Rubinstein, E, Pleil, A, Alvir, J

Get full text

Haemo PREF : Further evaluation of patient perception and preference for treatment in a real world setting by Bonanad, S., Schulz, M., Gordo, A., Spurden, D., Cicchetti, M., Cappelleri, J. C., Tolley, C., Staunton, H., Brohan, E.

“…Introduction Adherence to haemophilia A ( HA ) treatment may be influenced by patients’ beliefs about their condition and treatment. Furthermore, difficulties…”
Get full text

Further Validation of the Haemopref in a Real-World Setting by Tolley, C, Staunton, H, Brohan, E, Spurden, D, Cicchetti, M, Cappelleri, JC

Get full text